FI932769A0 - Farmaceutisk komposition med foerbaettrad biotillgaenglighet och innehaollande probukol - Google Patents

Farmaceutisk komposition med foerbaettrad biotillgaenglighet och innehaollande probukol

Info

Publication number
FI932769A0
FI932769A0 FI932769A FI932769A FI932769A0 FI 932769 A0 FI932769 A0 FI 932769A0 FI 932769 A FI932769 A FI 932769A FI 932769 A FI932769 A FI 932769A FI 932769 A0 FI932769 A0 FI 932769A0
Authority
FI
Finland
Prior art keywords
pharmaceutical composition
probukol
biotilgaenglighet
innehaollande
och
Prior art date
Application number
FI932769A
Other languages
English (en)
Other versions
FI102457B (fi
FI102457B1 (fi
FI932769A (fi
Inventor
Kenneth G Bassler
Deepak S Phadke
Melissa P Neddermeyer
Original Assignee
Merrell Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Pharma Inc filed Critical Merrell Pharma Inc
Publication of FI932769A0 publication Critical patent/FI932769A0/fi
Publication of FI932769A publication Critical patent/FI932769A/fi
Application granted granted Critical
Publication of FI102457B publication Critical patent/FI102457B/fi
Publication of FI102457B1 publication Critical patent/FI102457B1/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
  • Polyesters Or Polycarbonates (AREA)
FI932769A 1990-12-18 1993-06-16 Menetelmä probukolia sisältävän, parantuneen biosaatavuuden omaavan farmaseuttisen koostumuksen valmistamiseksi FI102457B1 (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US62954090A 1990-12-18 1990-12-18
US62954090 1990-12-18
US9108565 1991-11-15
PCT/US1991/008565 WO1992010996A1 (en) 1990-12-18 1991-11-15 Enhanced bioavailability pharmaceutical composition containing probucol

Publications (4)

Publication Number Publication Date
FI932769A0 true FI932769A0 (fi) 1993-06-16
FI932769A FI932769A (fi) 1993-06-16
FI102457B FI102457B (fi) 1998-12-15
FI102457B1 FI102457B1 (fi) 1998-12-15

Family

ID=24523438

Family Applications (1)

Application Number Title Priority Date Filing Date
FI932769A FI102457B1 (fi) 1990-12-18 1993-06-16 Menetelmä probukolia sisältävän, parantuneen biosaatavuuden omaavan farmaseuttisen koostumuksen valmistamiseksi

Country Status (17)

Country Link
EP (1) EP0563112B1 (fi)
JP (1) JP3127998B2 (fi)
KR (1) KR0177845B1 (fi)
AT (1) ATE117200T1 (fi)
AU (1) AU647563B2 (fi)
CA (1) CA2097827C (fi)
DE (1) DE69106892T2 (fi)
DK (1) DK0563112T3 (fi)
ES (1) ES2069987T3 (fi)
FI (1) FI102457B1 (fi)
GR (1) GR3015837T3 (fi)
HU (1) HU210565B (fi)
IE (1) IE65578B1 (fi)
IL (1) IL100390A (fi)
NO (1) NO303526B1 (fi)
NZ (1) NZ240961A (fi)
WO (1) WO1992010996A1 (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995031979A1 (en) * 1994-05-19 1995-11-30 R.P. Scherer International Corporation Solutions of aryl or heteroaryl substituted alkanoic acids in lipophilic solvents and soft gelatin capsules containing such solutions
US5858401A (en) 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
CA2355820A1 (en) * 1998-12-18 2000-06-29 Abbott Laboratories Novel formulations comprising lipid-regulating agents
US6814977B1 (en) 1998-12-18 2004-11-09 Abbott Laboratories Formulations comprising lipid-regulating agents
US7014864B1 (en) 1998-12-18 2006-03-21 Abbott Laboratories Formulations comprising lipid-regulating agents
US6838091B2 (en) 1998-12-18 2005-01-04 Abbott Laboratories Formulations comprising lipid-regulating agents
WO2000050029A1 (fr) * 1999-02-23 2000-08-31 Chugai Seiyaku Kabushiki Kaisha Preparations de capsules molles jonctionnees contenant des derives dihydrobenzofuranes
US6719999B2 (en) 1999-03-31 2004-04-13 Abbott Laboratories Formulations comprising lipid-regulating agents
US6372251B2 (en) 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
WO2005037251A1 (en) * 2003-10-17 2005-04-28 Amylin Pharmaceuticals, Inc. Self-emulsifying drug delivery systems for hydrophobic therapeutic compounds
CN112996494A (zh) 2018-06-26 2021-06-18 利博诺瓦公司 治疗线粒体功能障碍的方法
US12016830B2 (en) 2022-07-01 2024-06-25 Acrotech Biopharma, LLC Pharmaceutical compositions comprising isotretinoin and processes for preparation and uses thereof
CN116617179B (zh) * 2023-05-19 2024-03-29 齐鲁制药有限公司 一种普罗布考软胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3862332A (en) * 1967-05-11 1975-01-21 Dow Chemical Co Method of lowering serum cholesterol
US4902513A (en) * 1987-07-31 1990-02-20 Jean Carvais Oral sustained release medicament

Also Published As

Publication number Publication date
ATE117200T1 (de) 1995-02-15
CA2097827A1 (en) 1992-06-19
EP0563112B1 (en) 1995-01-18
KR0177845B1 (ko) 1999-03-20
HU9301769D0 (en) 1993-09-28
JPH06503340A (ja) 1994-04-14
HUT64218A (en) 1993-12-28
FI102457B (fi) 1998-12-15
ES2069987T3 (es) 1995-05-16
AU9067891A (en) 1992-07-22
KR930702965A (ko) 1993-11-29
AU647563B2 (en) 1994-03-24
NZ240961A (en) 1994-03-25
IL100390A (en) 1996-12-05
FI102457B1 (fi) 1998-12-15
CA2097827C (en) 2002-07-23
NO932236L (no) 1993-06-17
NO303526B1 (no) 1998-07-27
IE914401A1 (en) 1992-07-01
JP3127998B2 (ja) 2001-01-29
DE69106892T2 (de) 1995-05-18
DE69106892D1 (de) 1995-03-02
IE65578B1 (en) 1995-11-01
DK0563112T3 (da) 1995-04-10
EP0563112A1 (en) 1993-10-06
FI932769A (fi) 1993-06-16
IL100390A0 (en) 1992-09-06
HU210565B (en) 1995-05-29
GR3015837T3 (en) 1995-07-31
NO932236D0 (no) 1993-06-17
WO1992010996A1 (en) 1992-07-09

Similar Documents

Publication Publication Date Title
ATE153854T1 (de) Stabile pharmazeutische zubereitung mit fumagillolderivaten
FI932769A0 (fi) Farmaceutisk komposition med foerbaettrad biotillgaenglighet och innehaollande probukol
DE69526757D1 (de) Pentapeptid-Methylester, die menschliche Krebs hemmen
FI963424A0 (fi) Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi
FI913248A (fi) Kontrollerat frigoerande fast farmaceutisk doseringsform.
IT9021091A0 (it) Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composi- zioni ottenute
FI904395A0 (fi) 4-hydroxitetrahydropyran-2-oner samt motsvarande dihydroxikarboxylsyra derivat, salter och estrar, foerfarande foer deras framstaellning, deras anvaendning saosom laekemedel, farmaceutiska produkter samt foerprodukter.
DK585889D0 (da) Farmaceutisk praeparat
MX9101035A (es) Quinazolinonas biologicamente activas y composicion farmaceutica que las contiene
DK0458588T3 (da) Behandling af okulær hypertension med en synergistisk kombination til okulær administration
BE1002024A6 (fr) Preparation medicamenteuse a base de derives d'esters d'hecogenine et leur utilisation pour le traitement de l'hyperplasie prostatique benigne.
ATE126435T1 (de) Antiherpes-castanosperminester.
FI932253A (fi) Foerfarande och anordning foer administration av farmaceutiska partiklarsom kan inandas
FI911644A0 (fi) Terapeutisk foerening och komposition.
DE69104828D1 (de) Hydrocyanierung von konjugierten 2-alkencarbonsäureestern.
NO306381B1 (no) Farmasöytisk ampulle
IT1217628B (it) Forma farmaceutica e supporto per la somministrazione di estratti ellergenici
DZ1600A1 (fr) Compositions pharmaceutiques anti-glaucomateurses et leur procédé d'obtention.
FR2675047B1 (fr) Nouvelles compositions pharmaceutiques anti-glaucomateuses et leur procede d'obtention.
FR2679138B1 (fr) Compositions pharmaceutiques anti-glaucomateuses et leur procede d'obtention.
CS9001479A2 (en) Injection drug form on base of luteolytically active analogue of prostaglandin
KR920005980A (ko) 팽창선 병변의 예방 및 이의 크기를 감소시키기 위한 약제학적 조성물
CS9001478A2 (en) Injection drug form on base of luteolytically active analogue of f2 alpha prostaglandin
ITMI911206A1 (it) Formulazioni farmaceutiche per il trattamento di malattie periferiche vascolari a base di vincamina o di un suo sale farmaceuticamente accettabile.
IT8620737A1 (it) Composizioni farmaceutiche contenenti levodopa metil estere, loro procedimento di preparazione e relative applicazioni terapeutiche

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: AVENTIS INC.

Free format text: AVENTIS INC.

PC Transfer of assignment of patent

Owner name: AVENTISUB II INC.

Free format text: AVENTISUB II INC.

MA Patent expired